Your browser doesn't support javascript.
loading
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial.
Stebbing, Justin; Baranau, Yauheni; Baryash, Valeriy; Manikhas, Alexey; Moiseyenko, Vladimir; Dzagnidze, Giorgi; Zhavrid, Edvard; Boliukh, Dmytro; Stroyakovskii, Daniil; Pikiel, Joanna; Eniu, Alexandru; Komov, Dmitry; Morar-Bolba, Gabriela; Li, Rubi K; Rusyn, Andriy; Lee, Sang Joon; Lee, Sung Young; Esteva, Francisco J.
Afiliação
  • Stebbing J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Baranau Y; Chemotherapy Department #1, Minsk City Clinical Oncological Dispensary, Minsk, Belarus.
  • Baryash V; Department of Oncology, Belarusian State Medical University, Minsk, Belarus.
  • Manikhas A; Breast Cancer Department, City Clinical Oncology Dispensary, Saint Petersburg, Russia.
  • Moiseyenko V; St Petersburg Clinical Scientific and Practical Centre of Specialized Kinds of Medical Care (Oncologic), Saint Petersburg, Russia.
  • Dzagnidze G; Breast Unit, Khechinashvili University Hospital, Tbilisi, Georgia.
  • Zhavrid E; Chemotherapy Department, NN Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Minsk, Belarus.
  • Boliukh D; Surgical Department, Vinnytsya Regional Clinical Oncologic Dispensary, Vinnytsya, Ukraine.
  • Stroyakovskii D; Moscow City Oncology Hospital #62 of Moscow Healthcare Department, Moscow Oblast, Russia.
  • Pikiel J; Copernicus Wojewódzkie Centrum Onkologii Gdansk, Gdansk, Poland.
  • Eniu A; Department of Breast Tumors, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.
  • Komov D; Russian Cancer Research Center, Moscow, Russia.
  • Morar-Bolba G; Department of Breast Tumors, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.
  • Li RK; St Luke's Medical Center, Quezon City, Philippines.
  • Rusyn A; Transkarpathian Regional Oncology Clinic, Uzhgorod, Ukraine.
  • Lee SJ; Celltrion Inc, Incheon, South Korea.
  • Lee SY; Celltrion Inc, Incheon, South Korea.
  • Esteva FJ; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA. Electronic address: francisco.esteva@nyumc.org.
Lancet Oncol ; 18(7): 917-928, 2017 07.
Article em En | MEDLINE | ID: mdl-28592386

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Trastuzumab Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Trastuzumab Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article